Skip to content
Home/Companies/Pharma/Corealis
Corealis

Corealis

Pharma·Canada·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Corealis?

Corealis is a Canadian Pharma company, currently owned by ARCHIMED since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Investor
ARCHIMED
MED Platform II · 2022 · Buyout

Key facts

HQCanada
SectorPharma
Websitewww.corealispharma.com

More from MED Platform II

Other portfolio companies in the same fund.

Esperion Therapeutics
Active
· 2026
ARK Diagnostics
Active
MedTechUS· 2025
Instem
Instem
Active
HealthTechUS· 2023
Symbio
Symbio
Active
ClimateTechUS· 2023
WiQo
WiQo
Active
HealthTechItaly· 2023
Natus
Natus
Active
MedTechUS· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Corealis?

Corealis is currently owned by ARCHIMED, through MED Platform II, since 2022.

When did ARCHIMED acquire Corealis?

ARCHIMED acquired Corealis in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue